WHAT WE DO
August 3, 2017
Douglas Oliver MSW
I’m very positive about the future role of the FDA in ensuring that stem cell and related therapies are safe and effective.
And, because of that, I believe now is the appointed time for both patients and therapy providers to be intentional in helping to rewire their own...
July 11, 2017
Throughout the week of August 7th, I have visits in DC with top policymakers and regulators, politicians, stem cell industry leaders, researchers and CBER officials. We specialize in guiding providers wishing to conduct RMAT-Designated trials.
PIONEERS OF HOPE: Doug Oliver's Interview with U.S. Senator Susan Collins
July 26, 2018
PREDICTION # 1: “Exposure Enforcement” Against Stem Cell Clinics Is About To Get More Personal…
October 18, 2018
PIONEERS OF HOPE: Doug Oliver's Interview with Harry Reid
June 12, 2018
PIONEERS OF HOPE: Doug Oliver's Interview with Dr. Kapil Bharti, Ph.D., Principal Investigator for National Eye Institute's Regenerative Medic...
March 21, 2018
PIONEERS OF HOPE: Doug Oliver's Interview of Senator Bill Frist, Former Senate Majority Leader & Heart Transplant Surgeon
February 27, 2018
PIONEERS OF HOPE: Doug Oliver's Interview of Dr. Francis Collins, Director of NIH, for the Regenerative Medicine Foundation
February 2, 2018
Doug Oliver and the Regenerative Outcomes Foundation on the 21st Century Cures Act
January 19, 2018
FDA, Patients, and Providers: A Brand New “Relation-shift.”
What About Treatment #2?
July 27, 2017
An Ambassador In Your Corner
October 2018 (1)
July 2018 (1)
June 2018 (1)
March 2018 (1)